Has Scott Gillogly, MD received payments from drug or device companies?

Yes. Drug and device makers reported $65,938 in general payments to Scott Gillogly, MD across 127 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Gillogly, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Gillogly, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Gillogly, MD

Orthopaedic Surgery · Cartersville, GANPI 1477587723

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Vericel Corporation accounts for 87.6% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $14,876 and has fallen 94.5% since, to $811 in 2025. Among orthopaedic surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$65,938in general payments, 2019–2025

Across 127 payments — averaging $519.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vericel Corporation$58K
Medacta USA, Inc.$4K
ERMI LLC$2K
Arcuro Medical Inc$560
Johnson & Johnson$472
Maxx Orthopedics, Inc.$350
plus $1K from 14 others

What the payments were for

Consulting fees$20,47531%
Speaking & faculty fees$32,27549%
Travel & lodging$8,16012%
Food & beverage$5,0278%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vericel Corporation	44	$57,792
Medacta USA, Inc.	39	$4,132
ERMI LLC	1	$1,500
Arcuro Medical Inc	1	$560
Johnson & Johnson(2 entities)	12	$472
Maxx Orthopedics, Inc.	4	$350
Linkbio Corp	1	$185
Orthogenrx Inc.	8	$169
Osteocentric Technologies, Inc.	1	$139
Smith+Nephew	3	$126
Encore Medical, LP	2	$118
Anika Therapeutics, Inc.	1	$98
Baxter Healthcare	2	$94
Abanza Inc.	1	$70
Pacira Pharmaceuticals Incorporated	1	$34
Pacira Therapeutics, Inc.	2	$29
Medtronic	1	$23
Avanos Medical	1	$21
Amgen	1	$13
Integra Lifesciences Corporation	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MACI$57,414
AMISTEM$1,553
GMK SPHERE$683
PRIMARY SHOULDER$588
SUPERBALL$560
MOTO UNI$472
HEALIX KNOTLESS PEEK$250
Unifi Technology$139
TRUESPAN ORTHOCORD$129
DYNACORD$129
DYNATAPE$129
MECTA$121
DJO Surgical AltiVate Anatomic System$111
Freedom Total Knee System$104

How this compares

$65,938 in reported general payments places this provider in the 90th percentile of 654 orthopaedic surgery providers in Georgia.

See all orthopaedic surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$59,531

Medicare patients

Services billed

442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	106	$2,109
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	83	$608
Gabapentin	70	$606
Ibuprofen	60	$432
Ondansetron OdtOndansetron	56	$406
Tramadol Hcl	96	$263
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	30	$192
Acetaminophen-CodeineAcetaminophen With Codeine	11	$57
Meloxicam	19	$10

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Cartersville

Charles DecookCumming$48.3M
Ormonde MahoneyAthens$10.6M
Daxes BanitWarner Robins$5.5M
John DorchakColumbus$3.8M
Daniel SilcoxAtlanta$3.4M
Dennis DevitoAtlanta$1.5M
Jon MinterAlpharetta$1.2M
George GuildCumming$987K
William TallyAthens$870K
Julian PriceAthens$805K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →